Immunogenicity and Safety of the 9-valent Human Papillomavirus (HPV) Vaccine Administered as 2-Dose or 3-Dose Regimens in Japanese Boys and Girls Aged 9-15 Years.

Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42669546

Mariko Nakagomi; Miyuki Sawata; Motoharu Yonekawa; Nobuyuki Oshima; Shinya Murata; Yukako Fukao; Yuzuru Takeuchi

Aug 31, 2026